Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice (DIGILIB-RR)

June 30, 2026 updated by: ADIR Association

Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools.

A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients.

This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.

Study Overview

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France, 76000
        • ADIR Association

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients with chronic respiratory diseases.

Description

Inclusion Criteria:

  • Age superior to 18 years;
  • Referred for pulmonary rehabilitation in private physiotherapy practice.

Non-inclusion Criteria:

- Not applicable

Exclusion Criteria:

- Not applicable

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants
Physiotherapists and patients with chronic respiratory diseases participating in a pulmonary rehabilitation program in a private physiotherapy practice using a digital solution (TELEREHAPP).
Pulmonary rehabilitation supported by TELEREHAPP consisted of a program delivered in private physiotherapy practice using a digital health application designed to support the implementation, monitoring, and follow-up of rehabilitation and physical activity programs. Depending on the physiotherapist's usual practice and the patient's needs, the program could include endurance exercise training, muscle strengthening, physical activity coaching, self-administered questionnaires, and individualized monitoring by the physiotherapist. The digital solution was used as a support tool for care delivery and follow-up; the content, duration, frequency, and modalities of the program were determined by the treating physiotherapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiotherapist Adoption of the Digital Solution
Time Frame: 6 to 10 months
Proportion of equipped physiotherapists who used the solution to support at least one patient during the experimentation period.
6 to 10 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiotherapist Acceptance Rate
Time Frame: Baseline
Proportion of contacted physiotherapists who agreed to be equipped with the digital solution.
Baseline
Number of Patients Managed
Time Frame: 6 to 10 months
Total number of patients managed, number per physiotherapist, and number per physiotherapist per month.
6 to 10 months
Modules Used
Time Frame: 6 to 10 months
Types of modules used within the digital solution (endurance training, muscle strengthening, physical activity coaching, self-administered questionnaires).
6 to 10 months
Number of Sessions Completed
Time Frame: 6 to 10 months
Number of sessions completed for each module.
6 to 10 months
Program Duration
Time Frame: 6 to 10 months
Duration of the proposed programs.
6 to 10 months
Program Frequency
Time Frame: 6 to 10 months
Frequency of the proposed programs.
6 to 10 months
Physiotherapist Satisfaction
Time Frame: 6 to 10 months
Satisfaction of physiotherapists with the care pathway involving the digital solution, assessed using an adapted Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.
6 to 10 months
Patient Satisfaction
Time Frame: 6 to 10 months
Satisfaction of patients with the care pathway involving the digital solution, assessed using the Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.
6 to 10 months
Perceived Usability - Physiotherapists
Time Frame: 6 to 10 months
Perceived usability of the digital solution by physiotherapists, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.
6 to 10 months
Perceived Usability - Patients
Time Frame: 6 to 10 months
Perceived usability of the digital solution by patients, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.
6 to 10 months
Exercise Capacity - 6-Minute Walk Distance
Time Frame: 8 to 10 weeks
Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT) before and after the rehabilitation program. The test measures the distance walked in 6 minutes, expressed in meters, with higher values indicating greater exercise capacity.
8 to 10 weeks
Exercise Capacity - 6-Minute Stepper Test (6MST)
Time Frame: 8 to 10 weeks
Exercise capacity will be assessed using the 6-Minute Stepper Test (6MST) before and after the rehabilitation program. The outcome is the number of steps completed during the test over 6 minutes. Higher values indicate better exercise capacity.
8 to 10 weeks
Exercise Capacity - 1-Minute Sit-to-Stand Test (1STS)
Time Frame: 8 to 10 weeks
Exercise capacity will be assessed using the 1-Minute Sit-to-Stand Test (1STS) before and after the rehabilitation program. The test measures the number of sit-to-stand repetitions completed in 1 minute, with higher values indicating greater exercise capacity.
8 to 10 weeks
Health Status
Time Frame: 8 to 10 weeks
Health status will be assessed using the Chronic obstructive pulmonary disease Assessment Test (CAT) before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 to 40, with higher values indicating greater impairment of health status. The established minimal clinically important difference for this questionnaire is -2.5 points.
8 to 10 weeks
Respiratory Quality of Life
Time Frame: 8 to 10 weeks
Assessed using the Visual Simplified Respiratory Questionnaire (VSRQ). The score ranges from 0 to 80, with higher values indicating greater quality of life. The established minimal clinically important difference for this questionnaire is 3.4 points.
8 to 10 weeks
Psychological Status - Anxiety
Time Frame: 8 to 10 weeks
Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.
8 to 10 weeks
Psychological Status - Depression
Time Frame: 8 to 10 weeks
Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.
8 to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tristan Bonnevie, ADIR Association

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Actual)

June 1, 2026

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 30, 2026

First Posted (Actual)

July 7, 2026

Study Record Updates

Last Update Posted (Actual)

July 7, 2026

Last Update Submitted That Met QC Criteria

June 30, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be made available upon reasonable request for research purposes after publication. This includes de-identified data related to demographic characteristics, as well as endpoints published either in the main manuscript or any supplemental data. Requests should be sent to t.bonnevie@adir-hautenormandie.com

IPD Sharing Time Frame

Data will be made available after publication.

IPD Sharing Access Criteria

Data will be made available upon request, for research purpose. Request should be send to t.bonnevie@adir-hautenormandie.com

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiration Disorders

Clinical Trials on TELEREHAPP-supported pulmonary rehabilitation

3
Subscribe